Brand Access Landscape: Multiple Sclerosis
Unmet needs continue to exist even though the newest generation of Multiple Sclerosis (MS) disease-modifying therapies are considered safe and effective. Improving access in this market requires strong value propositions that tie back to unmet needs and/or dispel perceptions of limited intra-class differentiation.
Understand the evolving multiple sclerosis market landscape and gain the latest insights on the influencers and drivers that impact brand access in 2023 in this latest report from NAVLIN Insights.
A full report with additional insights is available as part of the NAVLIN Insights subscription. Contact us at [email protected] for access and to learn more about NAVLIN by EVERSANA and our innovative market research solutions.